128 related articles for article (PubMed ID: 16544314)
1. Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia?
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Balm AJ
Cancer; 2006 Apr; 106(8):1722-9. PubMed ID: 16544314
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation.
Robbins KT; Doweck I; Samant S; Vieira F
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):965-9. PubMed ID: 16301367
[TBL] [Abstract][Full Text] [Related]
4. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT).
Robbins KT; Doweck I; Samant S; Vieira F; Kumar P
Laryngoscope; 2004 Mar; 114(3):411-7. PubMed ID: 15091211
[TBL] [Abstract][Full Text] [Related]
5. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.
Goguen LA; Posner MR; Tishler RB; Wirth LJ; Norris CM; Annino DJ; Sullivan CA; Li Y; Haddad RI
Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):526-31. PubMed ID: 16702569
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
Vincens E; Balleyguier C; Rey A; Uzan C; Zareski E; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Cancer; 2008 Oct; 113(8):2158-65. PubMed ID: 18780318
[TBL] [Abstract][Full Text] [Related]
7. [Frequency and distribution pattern of distant metastases in patients with ENT tumors and their consequences for pretherapeutic staging].
Dietl B; Marienhagen J; Schaefer C; Pohl F; Kölbl O
Strahlenther Onkol; 2007 Mar; 183(3):138-43. PubMed ID: 17340072
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
9. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results.
Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
Eur J Radiol; 2008 Apr; 66(1):7-12. PubMed ID: 17604932
[TBL] [Abstract][Full Text] [Related]
10. Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?
Dequanter D; Lothaire P; Awada A; Lalami Y; Hien Nguyen T; Lemort M; Vandevelde L; Andry G
Acta Otolaryngol; 2006 Dec; 126(11):1225-8. PubMed ID: 17050318
[TBL] [Abstract][Full Text] [Related]
11. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck.
Rabbani A; Hinerman RW; Schmalfuss IM; Amdur RJ; Morris CG; Peters KR; Robbins KT; Mendenhall WM
Am J Clin Oncol; 2007 Jun; 30(3):283-6. PubMed ID: 17551306
[TBL] [Abstract][Full Text] [Related]
13. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
Lau H; Phan T; Mackinnon J; Matthews TW
Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
[TBL] [Abstract][Full Text] [Related]
14. Intraarterial infusion chemotherapy and conformal radiotherapy for cancer of the mouth: prediction of the histological response to therapy with magnetic resonance imaging.
Ishii A; Korogi Y; Hirai T; Nishimura R; Murakami R; Ikushima I; Kawanaka K; Shinohara M; Yamashita Y
Acta Radiol; 2007 Oct; 48(8):900-6. PubMed ID: 17924221
[TBL] [Abstract][Full Text] [Related]
15. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
17. Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging.
Lin D; Glastonbury CM; Rafaelian O; Eisele DW; Wang SJ
J Otolaryngol; 2007 Dec; 36(6):350-6. PubMed ID: 18076845
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.
Damascelli B; Patelli G; Tichá V; Di Tolla G; Frigerio LF; Garbagnati F; Lanocita R; Marchianò A; Spreafico C; Mattavelli F; Bruno A; Zunino F
J Vasc Interv Radiol; 2007 Nov; 18(11):1395-403. PubMed ID: 18003990
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma: a prospective study.
Bolzoni A; Cappiello J; Piazza C; Peretti G; Maroldi R; Farina D; Nicolai P
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):837-43. PubMed ID: 15262760
[TBL] [Abstract][Full Text] [Related]
20. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
